Consult with your Noom Med clinician before starting or stopping any medication
A recent meta-analysis including data from SURMOUNT-1, a trial conducted in individuals with obesity, confirmed the favorable effects of tirzepatide on dyslipidemia, finding a 16 and 13.7% change from baseline in triglycerides and very low-density lipoproteins with tirzepatide 15 mg vs
Our team has seen this play out time and again, and we believe understanding the roles of each provider is the first step toward achieving genuine, sustainable results
The result: Reduced appetite You feel genuinely satisfied with less food, not deprived Fewer cravings The constant mental chatter about food quiets down Slower digestion Food stays in your stomach longer, keeping you full between meals Better blood sugar control Fewer energy crashes and hunger spikes throughout the day Cardiovascular benefits Research shows reduced risk of heart attacks and strokes in people taking GLP-1 medications This isnt willpower in a syringe
Our turnkey systems make it easy to go live fast, stay compliant, and start serving patients nationwide
Marton A, Saffari SE, Rauh M, Sun RN, Nagel AM, Linz P, et al
:max_bytes(150000):strip_icc()/Common-Symptoms-From-Taking-a-GLP-1-And-How-to-Manage-Them-9e5bb7cee0484522a50dd9d7ce954cc4.jpg)
